Cost-effectiveness Analysis of Four Therapeutic Regimes for Acute Cerbral Infarction

@inproceedings{Sun2009CosteffectivenessAO,
  title={Cost-effectiveness Analysis of Four Therapeutic Regimes for Acute Cerbral Infarction},
  author={Xingwen Sun},
  year={2009}
}
Objective To evaluate the pharmacoeconomic effectiveness of four therapeutic regimes for acute cerbral infarction.Methods A total of 180 patients with acute cerbral infarction were divided into buflomedil(Group Ⅰ),sodium ozagrel(GroupⅡ),Shuxuetong(Group Ⅲ),Vinpocetine(Group Ⅳ),after equilibrating the influential factors among groups.The curative effects of the drugs were monitored by cost-effectiveness analysis.Results The costs of four groups were 6219.70,7129.7,5891.8,5123.4 yuan respectively… CONTINUE READING

Topics from this paper.